Related Experiment Video

Updated: Apr 29, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K

Development of molecular targeted drugs for advanced thyroid cancer in Japan

Hiroshi Takami1, Koichi Ito, Kiminori Sugino

  • 1Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.

Endocrine Journal
|May 23, 2014
PubMed

Insights

Novel molecular targeted drugs offer new hope for advanced thyroid cancer treatment. Sorafenib, vandetanib, and lenvatinib are nearing clinical availability in Japan, requiring careful differentiation for appropriate patient administration.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Advanced thyroid cancer historically lacked effective treatments.
  • Emerging molecular targeted drugs show promise by inhibiting tumor growth and angiogenesis.

Purpose of the Study:

  • To highlight the development of novel molecular targeted drugs for advanced thyroid cancer.
  • To introduce sorafenib, vandetanib, and lenvatinib as key therapeutic agents nearing clinical use in Japan.

Main Methods:

  • Review of ongoing global and Japanese drug development for advanced thyroid cancer.
  • Focus on drugs in late-stage trials or with international approval.

Main Results:

  • Sorafenib, vandetanib, and lenvatinib are in advanced development stages in Japan.
  • These targeted therapies are expected to be introduced clinically soon.

Conclusions:

  • The advent of molecular targeted drugs signifies a paradigm shift in advanced thyroid cancer treatment.
  • Understanding the distinct profiles of sorafenib, vandetanib, and lenvatinib will be crucial for optimal clinical application.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

24.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K